COMMUNIQUÉS West-GlobeNewswire

Oxford Immunotec to Participate in Two Investor Conferences This Week
26/11/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief [...]
Akorn Receives Product Approval
26/11/2018
LAKE FOREST, Ill., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a new Abbreviated New Drug Application (ANDA) approval from [...]
Canopy Rivers Reports Second Quarter Financial Highlights and Provides Corporate Update
26/11/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) today released its financial results [...]
XORTX Receives FDA Response on Orphan Drug Designation Application
26/11/2018
Pivotal Phase 2/3 Clinical Study in ADPKD Planned in 2019 CALGARY, Alberta, Nov. 26, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a biopharmaceutical company [...]
Arbutus Appoints Dr. Frank Torti as Chairman of its Board of Directors
26/11/2018
WARMINSTER, Pa., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Frank Torti has been [...]
IMV Leadership to Present Respiratory Syncytial Virus (RSV) Research at RespiDART 2018
26/11/2018
DARTMOUTH, Nova Scotia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that it will present data on its DPX-RSV program at “ RespiDART: [...]
Molecular Templates to Present at the Evercore ISI and BMO Healthcare Conferences
26/11/2018
AUSTIN, Texas, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered toxin bodies [...]
Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer
26/11/2018
COLUMBIA, Md., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
Abeona Therapeutics Announces CEO Transition
26/11/2018
Dr. Carsten Thiel to Depart Company Immediately; Dr. João Siffert Appointed Interim CEO NEW YORK and CLEVELAND, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage [...]
Abattis Bioceuticals Celebrates Release of Comfort Through Vergence Naturals
26/11/2018
VANCOUVER, British Columbia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the release of its first proprietary product, [...]
Amarin Announces Proposed Public Offering of American Depositary Shares
26/11/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced a registered underwritten public offering of its American Depositary Shares (“ADSs”). All of [...]
Transparency notification
26/11/2018
Mechelen, Belgium; 26 November 2018; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V . Pursuant to Belgian transparency [...]
G1 Therapeutics Announces Positive Myelopreservation Data from Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Trilaciclib in Combination with Chemotherapy/Tecentriq® in First-Line Small Cell Lung Cancer
26/11/2018
Second randomized, double-blind, placebo-controlled Phase 2 trial confirms multi-lineage myelopreservation benefits of trilaciclib in first-line small cell lung cancer (1L SCLC) Statistically significant improvements in [...]
CareDx Strengthens Executive Leadership Team with the Appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer
26/11/2018
BRISBANE, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high- [...]
Tyme Technologies, Inc. to Present at the Piper Jaffray Healthcare Conference on November 28th
26/11/2018
NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that it will be [...]
Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND
26/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced five poster presentations at the 29 th International Symposium on ALS/MND in Glasgow, Scotland, UK. The [...]
VitalHub Continues to Report Positive Adjusted EBITDA Results and Increased Revenues
26/11/2018
TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]
Xbrane Biopharma presents nomination committee
26/11/2018
Press release 2018-11-26 In accordance with the principles of the nomination committee of Xbrane Biopharma AB (" Company " or " Xbrane "), adopted at the Annual General Meeting on 24 May 2018, the Nomination Committee [...]
Hair Today, Gone Tomorrow: Dermatologists Debunk Common Misconceptions About Laser Hair Removal; American Academy of Dermatology
26/11/2018
AAD warns consumers that laser hair removal can be dangerous in inexperienced hands ROSEMONT, Ill., Nov. 26, 2018 (GLOBE NEWSWIRE) -- When performed by a doctor, laser hair removal is a safe, effective and permanent [...]

Pages